Clinical Study Evaluating Vildagliptin Versus Vildagliptin/Metformin on NAFLD With DM

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

dm Clinical Trial

Official title:
Clinical Study Evaluating the Effectiveness of Vildagliptin Versus Vildagliptin/Metformin on NAFLD With DM

Status Recruiting

Clinical Trial Summary

Clinical study evaluating vildagliptin versus vildagliptin/metformin on NAFLD with DM.

Clinical study evaluating vildagliptin versus vildagliptin/metformin on nonalcoholic fatty liver disease with DM. ;

NCT number	NCT03925701
Study type	Interventional
Source	Tanta University
Contact	Sherief Abd-Elsalam, ass. prof.
Phone	00201147773440
Email	sheriefabdelsalam@yahoo.com
Status	Recruiting
Phase	Phase 3
Start date	April 1, 2019
Completion date	December 2028

See also
Status	Clinical Trial	Phase
Completed	`NCT01094418` - Electrodiagnostic Parameters in Patients With Impaired Glucose Tolerance and Diabetes Mellitus	N/A
Completed	`NCT00587301` - Lap-Band Surgery on Adolescents for Safety and Efficacy	N/A
Recruiting	`NCT01830998` - Early Detection of Cognitive Dysfunction in Diabetes	N/A
Recruiting	`NCT05372458` - The Mechanism Study of Diabetic Pancreatic Amyloid Deposition on Cognitive Dysfunction in Alzheimer's Disease
Recruiting	`NCT03925714` - Impact of P53 and SIRT1 in Type 2 Diabetes	Phase 3